The Preclinical CRO Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
The preclinical CRO market has witnessed significant growth recently. The market size, which was at $5.7 billion in 2024 is expected to increase to $6.26 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 9.9%.
The Preclinical CRO Global Market Report 2025 forecasts that by 2029, the market size will reach $9.06 billion, growing at a compound annual growth rate (CAGR) of 9.7%.
Download Your Free Sample of the 2025 Preclinical CRO Market Report and Uncover Key Trends Now!The key drivers in the preclinical cro market are:
• Rising interest in personalized medicine
• Focus on rare diseases and orphan drugs
• Incline in outsourcing in biopharmaceuticals
• Focus on biomarker research and demand for real-world evidence generation
The preclinical CRO market covered in this report is segmented –
1) By Service: Bioanalysis And DMPK Studies, Toxicology Testing, Compound Management, Chemistry, Safety Pharmacology, Others Services
2) By Type: Patient Derived Organoid (PDO) Model, Patient Derived Xenograft Model
3) By Animal Model: Small Animal Model, Large Animal Model
4) By Model System: In Vivo, In Vitro
5) By End User: Biopharmaceutical Companies, Government And Academic Institutes, Medical Device Companies, Other End-users
The key trends in the preclinical cro market are:
• Integration of artificial intelligence (AI) is a key emerging trend.
• There is an expansion in the sphere of oncology research.
• Advances in omics technologies are shaping the future of the market.
• The market is seeing a rise in collaboration for translational research.
The major players in the preclinical cro market are:
• Eurofins Scientific SE
• PRA Health Sciences Inc
North America was the largest region in the preclinical CRO market in 2024